Product Description: Rosnilimab is a humanized IgG1-κ antibody targeting to PD-1[1][2].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Rosnilimab. IMGT/mAb-DB./[2]Pattabiraman, et al. Synthetic IL-7 and IL-7-anti-PD-1 antibody immunocytokines for cancer therapy. World Intellectual Property Organization, WO2023281484 A1 2023-01-12.